Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalMarket CapitalizationReturn on AssetsReturn on Capital EmployedReturn on Equity

Artiva Biotherapeutics (ARTV) EBITDA Margin: 2023-2024

Historic EBITDA Margin for Artiva Biotherapeutics (ARTV) over the last 1 years, with Mar 2024 value amounting to -5,603.19%.

  • Artiva Biotherapeutics' EBITDA Margin was N/A to -5,603.19% in Q1 2024 from the same period last year, while for Mar 2024 it was -103.54%, marking a year-over-year change of. This contributed to the annual value of -26,219.12% for FY2024, which is 2613429.00% down from last year.
  • Latest data reveals that Artiva Biotherapeutics reported EBITDA Margin of -5,603.19% as of Q1 2024, which was down 1,000.87% from -508.98% recorded in Q4 2023.
  • Artiva Biotherapeutics' 5-year EBITDA Margin high stood at 42.85% for Q3 2023, and its period low was -5,603.19% during Q1 2024.
  • Moreover, its 2-year median value for EBITDA Margin was -1,098.78% (2023), whereas its average is -1,939.47%.